Position in BMEA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$653,749
-$135,049 QoQ
Shares Held
444,728
-13.7% QoQ
Ownership
0.614%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 61 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMEA Over Time
Shares Held
Position Value (USD)
Derivatives in BMEA
reported options exposure · as of Dec 31, 2025CallValue
$973,772
CallShares
785,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. BMEA ranks #278 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in BMEA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $653,749 | 444,728 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $788,798 | 515,555 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $470,534 | 379,464 | Shares | Defined | 2026-01-29 | |
| 2025-12-31 | $973,772 | 785,300 | Call | Defined | 2026-01-29 | |
| 2025-09-30 | $190,954 | 94,532 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $445,792 | 247,663 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $504,544 | 236,876 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $489,031 | 126,039 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $346,460 | 34,303 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $216,031 | 48,007 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,949,775 | 264,199 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,064,490 | 73,312 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $767,807 | 55,800 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $781,134 | 35,587 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,767 | 186 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,289 | 1,102 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $39,902 | 4,080 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,198 | 100 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,583 | 355 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $54,369 | 7,298 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,197 | 100 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||